Who owns Arbutus Biopharma Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ABUS from SEC Form 13F filings across 216 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 216 institutions disclosed 132.6M shares of Arbutus Biopharma Corp worth $633.5M — about 66.7% of shares outstanding; the largest disclosed holder is MORGAN STANLEY. Source: SEC Form 13F filings, parsed by EvidInvest.
216
13F holders
$633.5M
value, 2026 filers
66.7%
of shares outstanding (132.6M sh)
66
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ABUS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 18.4M | $87.8M | 0.0% | 9.2% | +3.8% |
| 2 | BlackRock, Inc. | 14.5M | $69.4M | 0.0% | 7.3% | +5.4% |
| 3 | NOMURA HOLDINGS INC | 14.5M | $69.4M | 0.1% | 7.3% | +786.5% |
| 4 | Two Seas Capital LP | 8.1M | $38.9M | 0.4% | 4.1% | -57.4% |
| 5 | STATE STREET CORP | 7.1M | $33.8M | 0.0% | 3.6% | -10.0% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 7.0M | $33.4M | 0.0% | 3.5% | -0.3% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 4.1M | $19.7M | 0.0% | 2.1% | +0.1% |
| 8 | Rubric Capital Management LP | 3.3M | $16.0M | 0.2% | 1.7% | -55.6% |
| 9 | MILLENNIUM MANAGEMENT LLCNEW | 3.1M | $14.6M | 0.0% | 1.5% | new |
| 10 | GOLDMAN SACHS GROUP INC | 2.6M | $12.3M | 0.0% | 1.3% | -26.4% |
| 11 | BARCLAYS PLC | 2.5M | $12.2M | 0.0% | 1.3% | -39.4% |
| 12 | Legal & General Group Plc | 2.5M | $11.8M | 0.0% | 1.2% | +0.1% |
| 13 | Whitefort Capital Management, LP | 2.5M | $11.7M | 2.5% | 1.2% | -84.5% |
| 14 | BlackBarn Capital Partners LP | 2.2M | $10.6M | 0.9% | 1.1% | -11.4% |
| 15 | LMR Partners LLPNEW | 2.2M | $10.6M | 0.0% | 1.1% | new |
| 16 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.9M | $9.3M | 0.0% | 1% | +199.3% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.8M | $8.6M | 0.0% | 0.9% | +25.2% |
| 18 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.6M | $7.4M | 0.0% | 0.8% | +0.9% |
| 19 | NORTHERN TRUST CORP | 1.4M | $6.7M | 0.0% | 0.7% | -1.2% |
| 20 | LOS ANGELES CAPITAL MANAGEMENT LLC | 1.4M | $6.6M | 0.0% | 0.7% | +129.7% |
| 21 | OSAIC HOLDINGS, INC. | 1.3M | $6.3M | 0.0% | 0.7% | 0.0% |
| 22 | BANK OF AMERICA CORP /DE/ | 1.3M | $6.3M | 0.0% | 0.7% | -50.5% |
| 23 | Deltroit Asset Management (UK) LLP | 1.2M | $5.7M | 0.9% | 0.6% | 0.0% |
| 24 | Sagefield Capital LPNEW | 1.2M | $5.7M | 0.5% | 0.6% | new |
| 25 | D. E. Shaw & Co., Inc. | 1.2M | $5.6M | 0.0% | 0.6% | +205.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.